Evidence map›Paper›PMID 32035920›Full record

ArticleRedox biology2020

Hydrogen sulfide stimulates xanthine oxidoreductase conversion to nitrite reductase and formation of NO.

Sibile Pardue, Gopi K Kolluru, Xinggui Shen, Sara E Lewis, Courtney B Saffle, Eric E Kelley, Christopher G Kevil

Open access · goldAbstract read
In one paragraph

Article in Redox biology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 37 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Clinical Potential of Hydrogen Sulfide in Peripheral Arterial Disease.International journal of molecular sciences · 2023
    Review
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Sibile PardueDepartment of Pathology, LSU Health Sciences Center, Shreveport, LA, USA.
Gopi K KolluruDepartment of Pathology, LSU Health Sciences Center, Shreveport, LA, USA.
Xinggui ShenDepartment of Pathology, LSU Health Sciences Center, Shreveport, LA, USA.
Sara E LewisDepartment of Physiology and Pharmacology, West Virginia University, United States.
Courtney B SaffleDepartment of Physiology and Pharmacology, West Virginia University, United States.
Eric E KelleyDepartment of Physiology and Pharmacology, West Virginia University, United States.
Christopher G KevilDepartment of Pathology, LSU Health Sciences Center, Shreveport, LA, USA; Department of Cellular Biology and Anatomy, LSU Health Sciences Center, Shreveport, LA, USA; Department of Molecular and Cellular Physiology, LSU Health Sciences Center, Shreveport, LA, USA. Electronic address: ckevil@lsuhsc.edu.
Louisiana State University Health Sciences Center Shreveport · USWest Virginia University · US

Funding

West Virginia University Stroke COBREP20GM109098 · NIGMS · WEST VIRGINIA UNIVERSITY · PI HRUSKA, MARTIN · 2014 to 2024
$24.5M
Stress Exacerbates Myocardial Ischemic Injury by Blocking Estrogen's Antidoxidant Protection in the Female HeartP20GM121307 · NIGMS · LOUISIANA STATE UNIV HSC SHREVEPORT · PI Christopher G Kevil · 2018 to 2026
$23.6M
PROTEOMICSP01AG043376 · NIA · UNIVERSITY OF MINNESOTA · PI ROBBINS, PAUL D. · 2013 to 2019
$11.2M
CSE regulation of vascular remodelingR01HL149264 · NHLBI · LOUISIANA STATE UNIV HSC SHREVEPORT · PI KEVIL, CHRISTOPHER G · 2020 to 2023
$1.7M
NHLBI NIH HHS R01 HL149264NIA NIH HHS P01 AG043376NIGMS NIH HHS P20 GM109098NIGMS NIH HHS P20 GM121307
6 · The paper itself

Abstract

Cardiovascular disease is the leading cause of death and disability worldwide with increased oxidative stress and reduced NO bioavailability serving as key risk factors. For decades, elevation in protein abundance and enzymatic activity of xanthine oxidoreductase (XOR) under hypoxic/inflammatory conditions has been associated with organ damage and vascular dysfunction. Recent reports have challenged this dogma by identifying a beneficial function for XOR, under similar hypoxic/acidic conditions, whereby XOR catalyzes the reduction of nitrite (NO2

Indexed as

Hydrogen SulfideXanthine DehydrogenaseAnimalsEndothelial CellsMiceNitric OxideNitrite ReductasesHydrogen SulfideNitric OxideNitrite ReductasesXanthine DehydrogenaseHydrogen sulfideNitric oxideNitritePolysulfideSulfideXanthine oxidase

Identifiers

PMID32035920
PMCPMC7327988
OpenAlexW3004217996

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.